-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Elevation Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Elevation Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.2M, a 21.1% decline year-over-year.
- Elevation Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$42M, a 25% increase year-over-year.
- Elevation Oncology, Inc. annual Operating Income (Loss) for 2023 was -$45.4M, a 51.9% increase from 2022.
- Elevation Oncology, Inc. annual Operating Income (Loss) for 2022 was -$94.5M, a 195% decline from 2021.
- Elevation Oncology, Inc. annual Operating Income (Loss) for 2021 was -$32M, a 85.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)